Xeris Biopharma Holdings Cash Flow Statement (2020-2025) | XERS

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Operating Activities
Net Income -16.00M-21.86M-18.41M-27.52M-26.01M-50.79M-33.71M-26.18M-21.83M-12.93M-16.83M-19.84M-12.19M-13.39M-18.98M-15.01M-15.74M-5.11M-9.22M-1.93M0.62M
Share-based Compensation 2.14M2.46M2.51M3.67M2.74M3.30M3.15M2.94M2.77M2.56M2.93M2.46M2.77M3.77M4.23M6.77M3.60M4.44M5.01M7.64M
Deferred Taxes -0.68M0.68M-1.25M0.31M0.75M-3.32M
Gains from Investment Securities 0.16M-0.00M0.36M-0.08M0.17M0.42M0.02M0.86M20.04M19.08M3.43M0.05M0.08M0.17M8.00M0.86M0.48M
Cash from Operations -10.87M-23.96M-20.02M-22.61M-28.95M-48.41M-20.61M-17.75M-16.12M-26.14M-13.74M-14.61M7.47M-20.30M-10.35M-8.30M1.98M-10.03M0.18M18.43M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles -0.14M-0.15M0.90M2.71M2.71M2.71M2.71M2.71M2.71M2.71M2.71M2.71M2.71M2.71M2.71M2.71M2.71M2.71M
Amortization of Deferred Charges 0.27M0.25M0.24M0.23M0.27M0.22M0.50M0.40M0.49M0.55M0.60M0.60M0.51M0.60M0.80M0.80M0.81M0.84M0.80M0.80M
Depreciation & Amortization (CF) 0.45M0.34M0.32M0.32M0.35M0.32M0.35M0.36M0.37M0.36M0.39M0.39M0.36M0.33M0.28M0.31M0.31M0.32M0.33M0.34M
Change in Working Capital
Change in Receivables -5.05M2.06M3.36M1.27M-0.45M5.93M2.37M1.76M3.31M0.03M-0.64M15.74M-6.77M-1.78M5.03M-1.30M-0.72M5.92M6.72M0.70M
Change in Inventory 1.69M3.48M0.40M1.26M2.27M0.16M0.15M1.66M5.50M3.82M7.43M2.15M1.40M2.33M2.27M1.05M3.14M3.62M7.57M4.08M
Change in Account Payables -1.58M1.65M0.42M-0.90M4.35M2.17M-4.46M-2.71M0.69M6.93M0.08M0.30M-0.35M-4.47M-1.59M1.65M-5.20M4.06M-4.43M2.00M
Change in Accured Expenses 9.69M-2.79M3.37M4.07M7.91M-13.66M1.18M0.34M0.75M-13.93M2.73M-0.80M6.15M-1.12M2.95M0.47M1.35M-8.58M5.35M4.62M
Other Working Capital Changes 0.25M0.01M-0.96M1.33M-3.68M0.06M0.86M1.84M1.13M1.23M4.74M0.68M0.89M1.86M-0.28M-0.15M0.25M-1.53M-0.27M5.15M
Investing Activities
Capital Expenditures 0.23M0.13M
Change in Acquisitions & Divestments 17.84M34.65M29.00M29.45M10.50M6.70M12.10M6.88M9.30M10.00M15.00M15.00M5.00M10.00M15.00M10.24M
Cash from Investing Activities 7.25M26.30M16.56M18.50M36.60M6.72M11.87M6.71M9.17M-43.98M8.45M14.65M14.87M-19.65M4.60M9.91M10.02M-0.01M-0.28M-0.07M
Financing Activities
Other financing activities 0.06M0.05M4.36M0.30M0.16M0.06M1.19M
Cash from Financing Activities 3.33M26.66M0.46M0.00M0.12M78.19M0.31M-0.19M49.16M-0.86M0.56M-0.07M-1.23M35.19M0.66M-0.08M0.40M-3.14M0.94M13.85M
Additional items
Exchange Rate Effect 0.01M0.00M-0.00M-0.00M-0.00M0.00M
Change in Cash -0.29M29.01M-3.00M-4.11M7.78M36.50M-8.43M-11.23M42.20M-70.98M-4.74M-0.03M21.11M-4.76M-5.09M1.53M12.39M-13.18M0.84M32.21M
Beginning Cash Balance 37.89M37.89M-29.01M3.00M63.60M59.49M67.27M103.77M95.34M79.76M121.97M50.91M46.17M46.34M67.45M62.69M57.71M59.23M71.62M58.44M59.39M
Free Cash Flow -11.09M-23.96M-20.02M-22.61M-29.08M-48.41M-20.61M-17.75M-16.12M-26.14M-13.74M-14.61M7.47M-20.30M-10.35M-8.30M1.98M-10.03M0.18M18.43M
Net Cash Flow -0.29M29.01M-3.01M-4.11M7.78M36.50M-8.43M-11.23M42.20M-70.98M-4.74M-0.03M21.11M-4.76M-5.09M1.53M12.39M-13.18M0.84M32.21M